Article
Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients.
Cancer prevention research (Philadelphia, Pa.) - 1 Feb 2011
Lee J Jack, Wu Xifeng, Hildebrandt Michelle A T, Yang Hushan, Khuri Fadlo R, Kim Edward, Gu Jian, Ye Yuanqing, Lotan Reuben, Spitz Margaret R, Hong Waun Ki
Abstract excerpt
Head and neck squamous cell carcinoma (HNSCC) patients are at an increased risk of developing a second primary tumor (SPT) or recurrence following curative treatment. 13-cis-retinoic acid (13-cRA) has been tested in chemoprevention clinical trials, but the results have been inconclusive. We genot...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
